Even if the supply constraints are resolved, that doesn't impact the affordability issues with branded weight loss drugs, he added
Later in 2022, the FDA granted tirzepetide fast track designation for overweight and obesity in adults.6 To date, tirzepetide hasnt been FDA approved for weight loss (see table Current FDA-Approved Mono and Dual Agonists for details about weight management medications)
In Oregon, the PDAB meeting concluded the 2025 drug affordability review, with the board identifying Cosentyx, Trulicity, and Vraylar as posing affordability challenges and adding Lantus Solostar to meet statutory requirements
However, Ozempic itself remains approved primarily for managing blood glucose levels in patients with type 2 diabetes, and it is not officially indicated for weight loss in non-diabetic individuals
Patch behind ear changed every 3 days
If it sounds too good to be true, it probably is. Discuss Tapering or Microdosing Some people who cannot afford full access to GLP-1 medications try tapering or microdosing to stretch out their supply